Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vaccinex (VCNX)
:VCNX
Holding VCNX?
Track your performance easily
VCNX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.76 - $13.02
Previous CloseN/A
Volume245.00
Average Volume (3M)46.28K
Market Cap
$2.81M
Enterprise Value$5.57M
Total Cash (Recent Filing)$1.66M
Total Debt (Recent Filing)$1.04M
Price to Earnings (P/E)―
Beta1.47
Next Earnings
Mar 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-12.58
Shares Outstanding2,599,728
10 Day Avg. Volume2,889
30 Day Avg. Volume46,285
Standard Deviation0.26
R-Squared0.06
Alpha-0.08
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.39
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market Cap1.98
Enterprise Value/Revenue14.35
Enterprise Value/Gross Profit9.77
Enterprise Value/Ebitda-0.30
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Vaccinex News
Ownership Overview
52.86% Insiders
0.30% Mutual Funds
6.31% Other Institutional Investors
40.50% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
VCNX FAQ
What was Vaccinex’s price range in the past 12 months?
Vaccinex lowest stock price was $0.76 and its highest was $13.02 in the past 12 months.
What is Vaccinex’s market cap?
Vaccinex’s market cap is $2.81M.
When is Vaccinex’s upcoming earnings report date?
Vaccinex’s upcoming earnings report date is Mar 18, 2025 which is in 56 days.
How were Vaccinex’s earnings last quarter?
Vaccinex released its earnings results on Nov 18, 2024. The company reported -$2.828 earnings per share for the quarter, missing the consensus estimate of N/A by -$2.828.
Is Vaccinex overvalued?
According to Wall Street analysts Vaccinex’s price is currently Overvalued.
Does Vaccinex pay dividends?
Vaccinex does not currently pay dividends.
What is Vaccinex’s EPS estimate?
Vaccinex’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vaccinex have?
Vaccinex has 2,599,728 shares outstanding.
What happened to Vaccinex’s price movement after its last earnings report?
Vaccinex reported an EPS of -$2.828 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.582%.
Which hedge fund is a major shareholder of Vaccinex?
Currently, no hedge funds are holding shares in VCNX
---
Company Description
Vaccinex
Vaccinex, Inc. is a clinical-stage biotechnology company, which engages in the development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. Te firm focuses in the development of pepinemab for the treatment of non-small cell lung cancer, or NSCLC, osteosarcoma, melanoma and Huntington's disease. Its products pipeline include SEMA4D antibody platform and ActivMAb antibody discovery platform. The company was founded by Maurice Zauderer and Deepak Sahasrabudhe in 1997 and is headquartered in Rochester, NY.
---
Technical Analysis
Adaptimmune Therapeutics
―
Agenus
―
Bioxcel Therapeutics
―
Celldex
―
Fate Therapeutics
―
Immutep
―
---